CT Scans in Screening for Lung Cancer in Current and Former Smokers
NCT00625690 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2023-09-26
Summary
RATIONALE: Screening tests, such as CT scanning, may help doctors find cancer cells early and plan better treatment for lung cancer.
PURPOSE: This clinical trial is studying how well a lung cancer screening program using CT scanning works in current and former smokers.
Conditions
Interventions
- OTHER
-
questionnaire administration
Subjects will be asked to complete an additional detailed questionnaire regarding personal information about themselves, their medical history, their diet and lifestyle habits, any past or current environmental exposures and to re-create their family tree for any cancers that have occurred in any of their family members.
- PROCEDURE
-
computed tomography
The baseline and repeat screening CT scans will be performed with a multi-slice helical CT scanner (8 or more rows), at a low-dose setting (120kVp, 40-80mA, slice thickness of 1.25 mm or less). In a single breath-hold, contiguous slices from the thoracic inlet to the adrenal glands will be obtained. Contrast material will not be used. Multi-slice scanners will be used because they provide higher-resolution images. Diagnostic studies, including HRCT will be performed with a multi-slice helical CT at diagnostic settings (120kVp, 140-300mA, slice thickness of 1.25 or less) with the nodule retrospectively reconstructed at a 15cm field of view.
- PROCEDURE
-
evaluation of cancer risk factors
When the CT scan at baseline does not lead to the diagnosis of malignancy, repeat screening will be scheduled 12 months later. If the initial scan led to further evaluation, the repeat scan will be performed 12 months after the most recent scan. The subjects will be allowed to add relevant health information to their record in the web-based database as it develops. Similarly, when in the first repeat screening malignancy is not diagnosed; the second repeat screening will be scheduled 12 months later for a total period of 5 years.
- PROCEDURE
-
study of high risk factors
When the CT scan at baseline does not lead to the diagnosis of malignancy, repeat screening will be scheduled 12 months later. If the initial scan led to further evaluation, the repeat scan will be performed 12 months after the most recent scan. The subjects will be allowed to add relevant health information to their record in the web-based database as it develops. Similarly, when in the first repeat screening malignancy is not diagnosed; the second repeat screening will be scheduled 12 months later for a total period of 5 years.
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
University of Nebraska
lead OTHER
Principal Investigators
-
Apar K Ganti, MD · University of Nebraska
Eligibility
- Min Age
- 19 Years
- Max Age
- 120 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-05-19
- Primary Completion
- 2012-12-01
- Completion
- 2012-12-01
Countries
- United States
Study Locations
More Related Trials
-
Computed Tomography for Early Detection of Cancer in Women Who Are at Risk for Lung Cancer
NCT00012103 ·Status: COMPLETED ·Phase: NA
-
Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung Cancer
NCT05384769 ·Status: RECRUITING ·Phase: NA
-
Lung Cancer Screening in Family Members and Peers of Lung Cancer Patients: a Prospective Cohort Study
NCT05645731 ·Status: COMPLETED
-
Early Lung Cancer Detection Using Computed Tomography
NCT00188734 ·Status: COMPLETED
-
Low-dose Computed Tomography Screening for Lung Cancer in Relatives With Family History of Lung Cancer
NCT02519972 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Lung Cancer CT Screening Performance Among Former and Current Smokers
NCT05486455 ·Status: RECRUITING ·Phase: NA
-
PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First Chemotherapy
NCT02035683 ·Status: UNKNOWN ·Phase: NA
-
Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer
NCT07062172 ·Status: RECRUITING ·Phase: NA
-
Chest Imaging, Breath, and Biomarkers in a Screening Trial
NCT01663155 ·Status: COMPLETED
-
Nashville Early Diagnosis Lung Cancer Project
NCT01475500 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Early Cancer Biomarkers in Breath Condensate in Population of Individuals With High-Risk of Lung Cancer Undergoing LDCT Screening.
NCT06016569 ·Status: RECRUITING ·Phase: NA
-
CT in Diagnosing Patients With Lung Cancer
NCT01888510 ·Status: COMPLETED ·Phase: NA
-
CT Perfusion Scans for Assessment of Lung Cancer Before and After Chemo +/- Radiotherapy
NCT00188214 ·Status: COMPLETED ·Phase: PHASE2
-
Development and Pilot Testing of a Clinical Informatics Lung Cancer Screening Intervention
NCT02962115 ·Status: COMPLETED ·Phase: NA
-
Incorporating Veterans' Preferences Into Lung Cancer Screening Decisions
NCT02899754 ·Status: COMPLETED ·Phase: NA
-
Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer
NCT00603057 ·Status: COMPLETED
-
Circulating Tumor Cells (CTCs) as a Blood-based Tumor Marker in Patients With Small Cell Lung Cancer (SCLC)
NCT01173458 ·Status: COMPLETED
-
A Multi-Center Trial of the ProLung Test™
NCT01566682 ·Status: COMPLETED
-
A Study of Lung Cancer Screening in People With Unexplained Weight Loss
NCT06717334 ·Status: RECRUITING
-
Screening Methods in Finding Lung Cancer Early in Current or Former Smokers
NCT00751660 ·Status: UNKNOWN ·Phase: NA
-
Continuous Observation of Smoking Subject
NCT01248806 ·Status: COMPLETED
-
Lung Cancer Screening in High-risk Black Individuals
NCT05898594 ·Status: RECRUITING ·Phase: NA
-
Rural Illinois Lung Cancer Screening Initiative
NCT06084078 ·Status: RECRUITING
-
Non-Invasive Biomarkers For Early Detection Of Lung Cancers
NCT01580332 ·Status: COMPLETED
-
Benefit of Spectral Information in Patients Suspected for Lung Cancer
NCT06440616 ·Status: RECRUITING ·Phase: NA